telmisartan has been researched along with Dementia, Vascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, M; Gao, Y; Li, M; Li, W; Liu, Y; Wang, Y; Zhang, J | 1 |
| Abe, K; Deguchi, K; Fukui, Y; Hishikawa, N; Kono, S; Kurata, T; Liu, W; Omote, Y; Sato, K; Yamashita, T; Zhai, Y | 1 |
2 other study(ies) available for telmisartan and Dementia, Vascular
| Article | Year |
|---|---|
Effect of Telmisartan on Preventing Learning and Memory Deficits Via Peroxisome Proliferator-Activated Receptor-γ in Vascular Dementia Spontaneously Hypertensive Rats.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Benzimidazoles; Benzoates; Choline O-Acetyltransferase; Dementia, Vascular; Disease Models, Animal; Drug Partial Agonism; GPI-Linked Proteins; Hippocampus; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Maze Learning; Memory; Nootropic Agents; PPAR gamma; Rats, Inbred SHR; Signal Transduction; Synaptophysin; Telmisartan | 2018 |
Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Benzoates; Cerebral Cortex; Dementia, Vascular; Dose-Response Relationship, Drug; Hippocampus; Male; Mitogen-Activated Protein Kinase 1; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, LDL; Stroke; Telmisartan | 2014 |